SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-011605
Filing Date
2021-02-03
Accepted
2021-02-03 16:56:03
Documents
14
Period of Report
2021-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm214970d1_8k.htm   iXBRL 8-K 27593
2 EXHIBIT 99.1 tm214970d1_ex99-1.htm EX-99.1 385014
3 GRAPHIC tm214970d1_ex99-1img001.jpg GRAPHIC 22281
  Complete submission text file 0001104659-21-011605.txt   641341

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pahc-20210203.xsd EX-101.SCH 3175
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pahc-20210203_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pahc-20210203_pre.xml EX-101.PRE 22703
7 EXTRACTED XBRL INSTANCE DOCUMENT tm214970d1_8k_htm.xml XML 3673
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 21586954
SIC: 2834 Pharmaceutical Preparations